Supreme Court to Rule on Whether Breast Cancer Genes, Plants are Patentable
February 19, 2013 3:07 PM
Monsanto and Myriad are hopeful that the nation's highest court
20 percent of the human genome
is patented. Thousands of genetically modified plants and animals are patented as well. But those patents could soon be invalidated, depending on how the Supreme Court of the United States (SCOTUS) rules in a pair of key cases it will hear later this year.
I. Myriad and Patenting the Human Genome
The first case shaking the biotechnology agency is a lawsuit
Association for Molecular Pathology
Public Patent Foundation
(PUBPAT), and the
American Civil Liberties Union
(ACLU) against Myriad Genetics, Inc. (
) and the
University of Utah Research Foundation
Myriad and the University of Utah had patented a pair of genes -- BRCA1 and BRCA2 -- which are associated with breast cancer. They, and other human gene patent holders claim that isolating human genes makes them patentable, despite the same gene appearing in nature. They feel that their patents entitle them to block research on the human genes, unless various companies and research institutions pay their fees.
Myriad "owns" two critical human genes involved with breast cancer.
[Image Source: AU-KBC RESEARCH CENTRE]
Critics say this approach is unethical and immoral. They also argue that it illegal under provisions that "human organisms" [
] and "laws of nature" [
] are not patentable.
Judge Robert W. Sweet
, a federal judge with the
U.S. District Court for the Southern District of New York
, sided with the plaintiff's argument,
ruling that human gene patents were invalid
Now SCOTUS must decide whether to toss that decision, preserving the thousands of gene patents, or uphold it, throwing the biotech industry into chaos.
Oral arguments in the case
II. Monsanto and Second Generation GMO Seed
The other significant case involves a 75-year-old southwestern Indianan farmer's case
genetically modified organism (GMO) crop lines
. Lawyers for Vernon Hugh Bowman argue that companies like Monsanto should not be able to stake ownership to the offspring of GMO crops capable of reproduction.
Monsanto argues that ruling second-generation crops patent-free would "devastate innovation in biotechnology", commenting, "Investors are unlikely to make such investments if they cannot prevent purchasers of living organisms containing their invention from using them to produce unlimited copies."
One acre of GMO soybeans can produce enough beans to seed 26 acres of crop. In other words if the SCOTUS sides with Mr. Bowman, GMO seeds may be a one-time purchase for careful farmers.
Farmers are upset about Monsanto's lawsuits. [Image Source; AP/Greenpeace]
Currently, Monsanto requires farmers to sign contracts not to save seeds. It has filed 140 patent lawsuits against 410 farmers and 56 small farm businesses, according to The Center for Food Safety. While most of the cases were settled out of court, Monsanto scooped up $23.67M USD in judgements from the farmers who did try to fight it in court.
Mr. Bowman's case revolves around Roundup, a popular pesticide used on 90 percent of soybean crops in the U.S. Monsanto produced a special patented breed of soybean dubbed "Roundup Ready", which is immune to the herbicide.
Traditionally Mr. Bowman paid for a preliminary order of Roundup Ready soybean seeds each year. But for his second crop he bought commodity soybeans from a local grain elevator, as that crop is more often prone to fail and Monsanto's seed is expensive. The elevator grain consists of a blend of soybeans, most of which are Monsanto-derived crops. Mr. Bowman argues he should not be held accountable for using that crop.
In 2007 Monsanto sued Mr. Bowman and in 2009 the
U.S. District Court for the Southern District of Indiana
Mr. Bowman to pay $84,000 USD in damages. That decision
[PDF] in 2010 by the
U.S. Court of Appeals for the Federal Circuit
III. Monsanto Case Takes Different Angle: Patent Exhaustion
Unlike the Myriad case, the Monsanto case does not look to directly challenge the patentability of GMOs. Rather, it argues that GMO crops should be eligible for patent exhaustion -- once [their seeds] are sold, the patent should no longer apply, they argue.
Mr. Bowman has done much of the research for the case himself on a library loaned computer (as he does not own a PC). He is represented by
Mark P. Walters
of the firm Frommer Lawrence & Haug, which took the case on pro bono. Despite the firm offering its services pro bono, Mr. Bowman has still been forced to pay over $31,000 in legal fees.
Vernon H. Bowman [Image Source: Aaron P. Bernstein for The New York Times]
The New York Times
, he states, "I was prepared to let them run over me. but I wasn’t getting out of the road."
A date for the arguments has not been set.
Admittedly the cases are very different in several ways, but cumulatively they should prove a critical test of whether companies can reliably (and legally) patent living organisms.
The New York Times
"If you can find a PS3 anywhere in North America that's been on shelves for more than five minutes, I'll give you 1,200 bucks for it." -- SCEA President Jack Tretton
AntiSec Exposes U.S. Soldiers' S/Ns, Passwords, Vows Attack on Monsanto
July 12, 2011, 8:45 AM
U.S. Farmers Realize Disadvantages of Genetically Engineered Seed
October 5, 2010, 3:41 PM
Federal Court Rules it is Illegal to Patent Unaltered Human Genes
April 1, 2010, 12:00 PM
Twenty Percent of Human Genome is Patented, ACLU Battle to Determine Legality
January 22, 2010, 9:20 AM
PIQ ROBOTTM reveals its new artificial intelligence software
November 29, 2016, 12:59 AM
One more time - Happy Thanksgiving to Everyone Around the World
November 24, 2016, 4:00 AM
Google’s Smart Contact Lens Project gets halted for 2016
November 20, 2016, 7:00 AM
Cell Research Study shows African Americans have greater immune response to infection
November 10, 2016, 1:00 AM
UTHealth Clinical Trial Shows Progress Using Stem Cells to Treat Traumatic Brain Injury
November 8, 2016, 1:00 AM
Uber Partners with Circulation to Pilot Program Connecting Transportation and Digital Health Care
November 6, 2016, 5:00 AM
Most Popular Articles
Surface Pro 5 Rumors - New Release Date and Price
April 22, 2017, 6:45 AM
Vivo V5 Plus – the Selfie Softlight is on You.
April 17, 2017, 7:05 AM
What is the Apple’s iPhone 8 specifications and release date?
April 14, 2017, 5:43 AM
Meet the Smartphone with four cameras - Alcatel Flashphone
April 5, 2017, 11:20 AM
ASUS RT-AC5300 – Ultimate Game & 4K Streaming
April 18, 2017, 7:45 AM
Latest Blog Posts
Samsung Galaxy S8 – Warning for Pet Owners
Apr 24, 2017, 5:59 AM
Sound Bars and the Costs?
Apr 23, 2017, 6:30 AM
Link your Brain to Your Computer – In Four Years…Maybe
Apr 22, 2017, 7:03 AM
Google Home can now identify users by their voice.
Apr 21, 2017, 7:15 AM
Amazon Lex – Now Available for Developers.
Apr 20, 2017, 6:58 AM
You can now use Instagram offline on your Android Smartphone
Apr 19, 2017, 8:00 AM
Now you can livestream to YouTube from your mobile device.
Apr 18, 2017, 8:05 AM
Google Home – Is It a Spy Device?
Apr 17, 2017, 7:30 AM
Apple added to self –driving test permit list
Apr 15, 2017, 6:21 AM
Project Scorpio – Coming on June 11
Apr 14, 2017, 6:20 AM
Looks Like Samsung Has Been Forgiven.
Apr 13, 2017, 6:50 AM
United Airlines - Blasted on China’s Social Network and the Stock Market
Apr 12, 2017, 6:50 AM
Amazon's Third-Party Sellers Hacked
Apr 11, 2017, 6:25 AM
Microsoft Surface Pro5 Details Revealed
Apr 9, 2017, 6:41 AM
Own An Android Phone? Then you could be hacked over Wi-FI
Apr 7, 2017, 6:47 AM
Apple confirms iOS 10.3 bug and its effect on iCloud Services
Apr 6, 2017, 6:30 AM
Apple Rolls Out New Version of Apple Music
Apr 5, 2017, 10:35 AM
Apple in the News
Apr 4, 2017, 9:03 AM
Apple iPhones Will Soon Feature Graphics Chips Designed BY Apple
Apr 3, 2017, 6:23 AM
AMD Ryzen Desktop Processors Performance
Apr 2, 2017, 6:30 AM
What makes a camera Lensless?
Apr 1, 2017, 7:45 AM
Google halts Android Wear 2.0 Update Due to Bug
Mar 31, 2017, 7:27 AM
More Blog Posts
Copyright 2017 DailyTech LLC. -
Terms, Conditions & Privacy Information